XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2021   60,879,496        
Beginning balance at Dec. 31, 2021 $ (196,944) $ 61 $ 964,401 $ (1,106,377) $ (31) $ (54,998)
Increase (Decrease) in Stockholders' Equity            
Vesting of restricted stock units and performance-based restricted stock units (in shares)   55,286        
Vesting of ESPP Shares (in shares)   123,785        
Vesting of ESPP Shares 431   431      
Stock-based compensation 4,436   4,436      
Other comprehensive gain (loss) (232)       (232)  
Net loss (56,731)     (56,731)    
Ending balance (in shares) at Mar. 31, 2022   61,058,567        
Ending balance at Mar. 31, 2022 (249,040) $ 61 969,268 (1,163,108) (263) (54,998)
Beginning balance (in shares) at Dec. 31, 2022   74,570,198        
Beginning balance at Dec. 31, 2022 (323,778) $ 75 1,071,183 (1,340,036) (2) (54,998)
Increase (Decrease) in Stockholders' Equity            
Vesting of restricted stock units and performance-based restricted stock units (in shares)   372,117        
Vesting of ESPP Shares (in shares)   95,654        
Vesting of ESPP Shares 502   502      
Stock-based compensation 2,903   2,903      
Issuance of common stock, warrants, and pre-funded warrants, net of issuance costs (in shares)   12,205,000        
Issuance of common stock, warrants, and pre-funded warrants, net of issuance costs 52,428 $ 12 52,416      
Other comprehensive gain (loss) 1       1  
Net loss (61,719)     (61,719)    
Ending balance (in shares) at Mar. 31, 2023   87,242,969        
Ending balance at Mar. 31, 2023 $ (329,663) $ 87 $ 1,127,004 $ (1,401,755) $ (1) $ (54,998)